← Back to Search
A Phase II Study Of Nivolumab: A Multicenter, Open-label, Single Arm Study In Malignant Pleural Mesothelioma (MERIT)
Keisuke Aoe, Morihito Okada, Takashi Kijima, Terufumi Kato, Nobukazu Fujimoto, Kazuhiko Nakagawa, Yuichiro Takeda, Toyoaki Hida, Kuninobu Kanai, Fumio Imamura, Satoshi Oizumi, Toshiaki Takahashi, Mitsuhiro Takenoyama, Hiroshi Tanaka, Yuichiro Ohe